{"id":"W7097249647","doi":"","title":"Reason for posting: Coxibs,","year":2005,"lang":"en","type":"article","venue":"","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Valdecoxib; Adverse effect; Clinical trial; Cyclooxygenase; Key (lock); Class (philosophy)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001496254,0.001098366,0.001598319,0.0009887731,0.001490831,0.003746655,0.001352322,0.01012617,0.3998568],"category_scores_gemma":[0.01422626,0.0004627738,0.001134445,0.0009696711,0.001068555,0.003363237,0.001011067,0.004755358,0.3027861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001479537,"about_ca_system_score_gemma":0.002650264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001862714,"about_ca_topic_score_gemma":0.003316728,"domain_scores_codex":[0.9984921,0.0001813947,0.0002215845,0.0001947238,0.0006405244,0.0002696694],"domain_scores_gemma":[0.9918705,0.001203359,0.0007674487,0.0006614089,0.003130055,0.002367217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001136494,0.0000319412,0.0001765804,0.0001126011,0.000006350469,0.0001875789,0.0000108421,0.00001748653,0.0001066155,0.0005108964,0.9834325,0.01529311],"study_design_scores_gemma":[0.0001378406,0.00006553382,0.000940682,0.0001421619,0.000006460953,0.0002669929,0.00005297837,0.00007214381,0.0001521567,0.000530512,0.9976187,0.00001374688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.002127142,0.00764136,0.001497787,0.3087029,0.4097432,0.001274091,0.006018282,0.002507333,0.2604879],"genre_scores_gemma":[0.01092528,0.004922151,0.0009542393,0.1480314,0.1350617,0.0004903887,0.003178348,0.000529413,0.695907],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.6001432,"threshold_uncertainty_score":0.8560314,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01303236724779448,"score_gpt":0.2943978423158441,"score_spread":0.2813654750680496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}